NASDAQ:EXPO

Exponent - EXPO Stock Forecast, Price & News

$88.11

-0.89 (-1.00%)

(As of 10/6/2022 01:46 PM ET)

Add

Compare

Today's Range: $87.74
▼
$88.44
50-Day Range: $87.67
▼
$104.14
52-Week Range: $80.97
▼
$127.61

Volume: 2,928 shs
Average Volume: 194,674 shs
Market Capitalization: $4.57 billion

P/E Ratio: 46.62
Dividend Yield: 1.06%
Price Target: $120.00

Exponent MarketRank™ Forecast

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 36.4% Upside
$120.00 Price Target
Short Interest: Bearish
2.91% of Float Sold Short
Dividend Strength: Moderate
Based on Four Factors
Sustainability: N/A
News Sentiment: N/A
Insider Trading: Selling Shares
$1.17 M Sold Last Quarter
Proj. Earnings Growth: 10.27%
From $1.85 to $2.04 Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.63 out of 5 stars

Business Services Sector

55th out of 331 stocks

Management Consulting Services Industry

4th out of 18 stocks

3.5

Analyst's Opinion

Consensus Rating
Exponent has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $120.00, Exponent has a forecasted upside of 36.4% from its current price of $87.97.
Amount of Analyst Coverage
Exponent has received no research coverage in the past 90 days.

2.0

Short Interest

Percentage of Shares Shorted
2.91% of the float of Exponent has been sold short.
Short Interest Ratio / Days to Cover
Exponent has a short interest ratio ("days to cover") of 8.1.
Change versus previous month
Short interest in Exponent has recently increased by 1.38%, indicating that investor sentiment is decreasing.

2.5

Dividend Strength

Dividend Yield
Exponent pays a meaningful dividend of 1.06%, higher than the bottom 25% of all stocks that pay dividends.
Dividend Growth
Exponent has only been increasing its dividend for 4 years.
Dividend Coverage
The dividend payout ratio of Exponent is 50.79%. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, Exponent will have a dividend payout ratio of 47.06% next year. This indicates that Exponent will be able to sustain or increase its dividend.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for EXPO.

1.1

News and Social Media Coverage

News Sentiment
Exponent has a news sentiment score of 0.06. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.55 average news sentiment score of Business Services companies.

2.5

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Exponent insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,173,117.00 in company stock.
Percentage Held by Insiders
Only 2.00% of the stock of Exponent is held by insiders.
Percentage Held by Institutions
90.41% of the stock of Exponent is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

2.5

Earnings and Valuation

Earnings Growth
Earnings for Exponent are expected to grow by 10.27% in the coming year, from $1.85 to $2.04 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Exponent is 46.55, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 117.81.
Price to Earnings Ratio vs. Sector
The P/E ratio of Exponent is 46.55, which means that it is trading at a less expensive P/E ratio than the Business Services sector average P/E ratio of about 217.12.
Price to Book Value per Share Ratio
Exponent has a P/B Ratio of 11.00. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Exponent (NASDAQ:EXPO) Stock

Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company worldwide. It operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering. The Environmental and Health segment offers services in the areas of chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences, and health sciences. The company offers approximately 90 technical disciplines to solve pressing and complicated challenges facing stakeholders. It serves clients in chemical, construction, consumer products, energy, food, beverage and nutrition, government, life sciences, insurance, manufacturing, technology, industrial equipment, transportation, and other sectors of the economy. The company was formerly known as The Failure Group, Inc. and changed its name to Exponent, Inc. in 1998. Exponent, Inc. was founded in 1967 and is headquartered in Menlo Park, California.

Receive EXPO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Exponent and its competitors with MarketBeat's FREE daily newsletter.

EXPO Stock News Headlines

September 19, 2022 | finance.yahoo.com

Investors Should Be Encouraged By Exponent's (NASDAQ:EXPO) Returns On Capital

September 12, 2022 | nasdaq.com

Investors Shouldn't Overlook Exponent's (NASDAQ:EXPO) Impressive Returns On Capital - Nasdaq

August 17, 2022 | techcrunch.com

India’s Exponent Energy may have found the secret to 15 min rapid EV charging - TechCrunch

August 8, 2022 | investors.com

Exponent Reaches 80-Plus Relative Strength Rating Benchmark | Investor's Business Daily - Investor's Business Daily

August 1, 2022 | investors.com

Stocks With Rising Relative Strength: Exponent | Investor's Business Daily - Investor's Business Daily

July 30, 2022 | greenwichtime.com

Exponent: Q2 Earnings Snapshot - Greenwich Time

July 30, 2022 | finance.yahoo.com

Exponent Reports Second Quarter 2022 Financial Results - Yahoo Finance

July 28, 2022 | investing.com

Exponent, Inc. Tops Q2 EPS by 4c By Investing.com - Investing.com

July 28, 2022 | globenewswire.com

Exponent Reports Second Quarter 2022 Financial Results - GlobeNewswire

July 28, 2022 | finance.yahoo.com

Exponent (EXPO) Q2 Earnings Surpass Estimates

July 28, 2022 | benzinga.com

Exponent Declares Regular Quarterly Dividend - Benzinga

July 28, 2022 | uk.investing.com

Exponent, Inc. Tops Q2 EPS by 4c By Investing.com - Investing.com UK

July 28, 2022 | benzinga.com

Exponent: Q2 Earnings Insights - Benzinga

July 28, 2022 | apnews.com

Exponent: Q2 Earnings Snapshot - The Associated Press - en Español

July 28, 2022 | finance.yahoo.com

Exponent Reports Second Quarter 2022 Financial Results

July 26, 2022 | nasdaq.com

Do Exponent's (NASDAQ:EXPO) Earnings Warrant Your Attention? - Nasdaq

July 8, 2022 | benzinga.com

Exponent to Announce Second Quarter of Fiscal Year 2022 Results and Host Quarterly Conference Call on July 28, 2022 - Benzinga

July 7, 2022 | finance.yahoo.com

Exponent to Announce Second Quarter of Fiscal Year 2022 Results and Host Quarterly Conference Call on July 28, 2022

July 5, 2022 | finance.yahoo.com

Here's Why We Think Exponent (NASDAQ:EXPO) Is Well Worth Watching

June 7, 2022 | finance.yahoo.com

Here’s Why Polen Capital Sold its Exponent (EXPO) Shares

June 2, 2022 | finance.yahoo.com

Exponent's (NASDAQ:EXPO) investors will be pleased with their splendid 213% return over the last five years

May 31, 2022 | benzinga.com

EmsanaRx, True Choice America and Exponent Health Announce Partnership to Provide Innovative Pharmacy Ben - Benzinga

May 23, 2022 | globenewswire.com

Exponent to Present at Upcoming Investor Conferences - GlobeNewswire

May 19, 2022 | finance.yahoo.com

After Plunging 22.8% in 4 Weeks, Here's Why the Trend Might Reverse for Exponent (EXPO)

May 17, 2022 | finance.yahoo.com

Exponent Health Welcomes Industry Expert, Suresh Kumar, as New Chief Transformation Officer - Helping Lead the Future of the Company with National Healthcare Cost Reduction, Using the Power of Expio™ - Yahoo Finance

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive EXPO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Exponent and its competitors with MarketBeat's FREE daily newsletter.

EXPO Company Calendar

Last Earnings: 7/28/2022
Ex-Dividend for 9/23 Dividend: 9/08/2022
Dividend Payable: 9/23/2022
Today: 10/06/2022
Next Earnings (Estimated): 10/27/2022
Fiscal Year End: 12/31/2022

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Management consulting services
Sub-Industry: Research & Consulting Services
Sector: Business Services
Current Symbol: NASDAQ:EXPO
CUSIP: 30214U10
CIK: 851520
Web: www.exponent.com
Phone: (650) 326-9400
Fax: 650-326-8072
Employees: 1,215
Year Founded: 1967

Price Target and Rating

Average Stock Price Forecast: $120.00
High Stock Price Forecast: $120.00
Low Stock Price Forecast: $120.00
Forecasted Upside/Downside: +36.2%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): $1.89
Trailing P/E Ratio: 46.62
Forward P/E Ratio: 47.63
P/E Growth: N/A
Net Income: $101.20 million
Net Margins: 20.53%
Pretax Margin: 26.46%
Return on Equity: 25.93%
Return on Assets: 15.99%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 2.69
Quick Ratio: 2.69

Sales & Book Value

Annual Sales: $466.27 million
Price / Sales: 9.79
Cash Flow: $1.82 per share
Price / Cash Flow: 48.49
Book Value: $8.00 per share
Price / Book: 11.01

Miscellaneous

Outstanding Shares: 51,820,000
Free Float: 50,786,000
Market Cap: $4.57 billion
Optionable: Optionable
Beta: 0.60

Social Links

Key Executives

Dr. Catherine Ford Corrigan P.E. (Age 53)
Ph.D., Pres, CEO & Director
Comp: $1.72M

Mr. Richard L. Schlenker Jr. (Age 56)
Exec. VP, CFO & Corp. Sec.
Comp: $1.11M

Dr. Maureen T. F. Reitman Sc.D. (Age 53)
F.S.P.E., P.E., Corp. VP - Polymers Science & Materials Chemistry, Principal Engineer and Practice Director
Comp: $945.06k

Dr. Steven J. Murray P.E. (Age 47)
Ph.D., Group VP & Principal Engineer
Comp: $928.25k

Dr. Bernard Ross
Co-Founder, Chairman Emeritus & Principal Engineer

Dr. Subbaiah V. Malladi (Age 75)
CTO & Principal Engineer

Ms. Sally B. Shepard (Age 61)
Chief HR Officer

Mr. Eric R. Anderson
VP & Corp. Controller

Dr. Robert D. Caligiuri FASM (Age 70)
P.E., Ph.D., Corp. VP of Materials & Corrosion Engineering and Principal Engineer

Dr. Paul D. Boehm Ph.D. (Age 73)
Corp. VP of Environmental & Health Sciences and Principal Scientist

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

EXPO Stock - Frequently Asked Questions

Should I buy or sell Exponent stock right now?: 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Exponent in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "buy" EXPO shares.
View EXPO analyst ratings or view top-rated stocks.
What is Exponent's stock price forecast for 2022?: 1 brokers have issued 12 month price objectives for Exponent's stock. Their EXPO share price forecasts range from $120.00 to $120.00. On average, they anticipate the company's share price to reach $120.00 in the next twelve months. This suggests a possible upside of 34.8% from the stock's current price.
View analysts price targets for EXPO or view top-rated stocks among Wall Street analysts.
How have EXPO shares performed in 2022?: Exponent's stock was trading at $116.73 at the beginning of the year. Since then, EXPO stock has decreased by 23.8% and is now trading at $89.00.
View the best growth stocks for 2022 here.
When is Exponent's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, October 27th 2022.
View our EXPO earnings forecast.
How were Exponent's earnings last quarter?: Exponent, Inc. (NASDAQ:EXPO) announced its quarterly earnings data on Thursday, July, 28th. The business services provider reported $0.49 EPS for the quarter, topping analysts' consensus estimates of $0.45 by $0.04. The business services provider earned $130.28 million during the quarter, compared to the consensus estimate of $118.53 million. Exponent had a net margin of 20.53% and a trailing twelve-month return on equity of 25.93%. The firm's quarterly revenue was up 8.7% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.48 earnings per share.
How often does Exponent pay dividends? What is the dividend yield for Exponent?: Exponent declared a quarterly dividend on Thursday, July 28th. Shareholders of record on Friday, September 9th will be given a dividend of $0.24 per share on Friday, September 23rd. This represents a $0.96 annualized dividend and a yield of 1.08%. The ex-dividend date of this dividend is Thursday, September 8th.
Read our dividend analysis for EXPO.
Is Exponent a good dividend stock?: Exponent (NASDAQ:EXPO) pays an annual dividend of $0.96 per share and currently has a dividend yield of 1.06%. The company has been increasing its dividend for 4 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio is 50.79%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, EXPO will have a dividend payout ratio of 47.06% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for EXPO.
When did Exponent's stock split?: Exponent shares split on the morning of Thursday, June 7th 2018. The 2-1 split was announced on Tuesday, May 15th 2018. The newly issued shares were distributed to shareholders after the closing bell on Wednesday, June 6th 2018. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

What is Catherine Corrigan's approval rating as Exponent's CEO?: 15 employees have rated Exponent Chief Executive Officer Catherine Corrigan on Glassdoor.com. Catherine Corrigan has an approval rating of 84% among the company's employees.
What other stocks do shareholders of Exponent own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Exponent investors own include AbbVie (ABBV), Pfizer (PFE), Abbott Laboratories (ABT), Energy Transfer (ET), Ford Motor (F), Micron Technology (MU), AT&T (T), UnitedHealth Group (UNH), Visa (V) and Adobe (ADBE).
What is Exponent's stock symbol?: Exponent trades on the NASDAQ under the ticker symbol "EXPO."
How do I buy shares of Exponent?: Shares of EXPO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Exponent's stock price today?: One share of EXPO stock can currently be purchased for approximately $89.00.
How much money does Exponent make?: Exponent (NASDAQ:EXPO) has a market capitalization of $4.61 billion and generates $466.27 million in revenue each year. The business services provider earns $101.20 million in net income (profit) each year or $1.89 on an earnings per share basis.
How many employees does Exponent have?: The company employs 1,215 workers across the globe.
Does Exponent have any subsidiaries?: The following companies are subsidiares of Exponent: Dennis Publishing.
Read More
How can I contact Exponent?: Exponent's mailing address is 149 COMMONWEALTH DRIVE, MENLO PARK CA, 94025. The official website for the company is www.exponent.com. The business services provider can be reached via phone at (650) 326-9400, via email at investor-relations@exponent.com, or via fax at 650-326-8072.

This page (NASDAQ:EXPO) was last updated on 10/6/2022 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial